Semaglutide
Also known as: Ozempic, Wegovy, Rybelsus, GLP-1 receptor agonist
Semaglutide is a synthetic peptide that acts as a glucagon-like peptide-1 (GLP-1) receptor agonist. It mimics a natural gut hormone involved in blood sugar regulation and appetite signaling. It is available as an injectable and, in one formulation, as an oral tablet.
How it works
Research describes semaglutide as binding to GLP-1 receptors, which are found in the pancreas, brain, and gastrointestinal tract. Published studies report that this stimulates insulin release in a glucose-dependent manner, slows gastric emptying, and acts on brain regions associated with appetite. These mechanisms are how researchers explain its observed effects on blood glucose and food intake.
Researched uses
- Studied for glycemic control in type 2 diabetes
- Studied for chronic weight management in adults with obesity or overweight
- Studied for reducing cardiovascular risk in adults with type 2 diabetes and established heart disease
- Studied for reducing major cardiovascular events in adults with obesity and established cardiovascular disease
- Studied in ongoing research for conditions such as non-alcoholic steatohepatitis and chronic kidney disease
FDA-approved as branded products. Ozempic (subcutaneous) and Rybelsus (oral) are approved for type 2 diabetes. Wegovy (subcutaneous) is approved for chronic weight management. These are prescription-only. Compounded semaglutide has been dispensed by licensed compounding pharmacies during periods of FDA-recognized shortage, under specific regulatory conditions and a valid prescription. Compounded versions are not FDA-approved products, and their availability is tied to shortage status and applicable regulations, which can change.
Semaglutide providers compared
Providers that have passed our rubric review are listed first, then ordered by the total cost of a 3-month protocol. We average every cost to a standard 3-month protocol, which our medical advisors consider the best basis for comparing cost and value, and the headline figure folds in any one-time consult or provider-review fee plus three months of membership. Use the calculator below to adjust the length and see the same total broken out.
| Provider | Sourcing | What's included | Verified | Visit provider | |
|---|---|---|---|---|---|
RxPepsDirectVerified Semaglutide/B12 | 503A pharmacy | $114 for 3 months (est.) ≈3 vials · $25/vial incl. $39 consult | Consult fee extra · no membership | Jul 8, 2026 vial price | View |
We average every cost to a standard 3-month protocol, which our medical advisors consider the best window for comparing cost and value. Monthly plans are multiplied by 3 and 3-month programs are taken as billed; each provider's own sticker price and cadence are shown underneath.
The headline figure is the total 3-month cost: the medication plus any one-time consult or provider-review fee (for example RxPepsDirect's $39) and three months of any membership fee. Where a fee is not published we fold in what is known and flag that other fees may apply.
Per-vial providers are averaged to a 3-month protocol at roughly one vial per month (3 vials), marked "est.", with the per-vial price shown underneath. Actual vial count depends on your dose and protocol.
Prices are gathered from each provider's public pages. The "Verified" date is when we last checked the provider's sticker price; for per-vial providers it is the vial price that was verified, not the averaged 3-month total.
Value check: total cost of therapy
This is the real value comparison. A sticker price hides consult and membership fees, so this adds everything up for a full protocol of Semaglutide and ranks by true total cost. We default to a 3-month protocol, the window our medical advisors consider best for judging value.
Per-vial providers are estimated at about one vial per month (3 vials for 3 months), plus any one-time consult. Actual vial count depends on your dose and protocol, so the real cost may run higher or lower.
Safety notes
Clinical trials reported gastrointestinal side effects most commonly, including nausea, vomiting, diarrhea, and constipation. Labeling includes a boxed warning about thyroid C-cell tumors observed in rodent studies; relevance to humans is not determined. Reported risks also include pancreatitis, gallbladder problems, and hypoglycemia when combined with certain other agents. For compounded versions, product quality, identity, and potency are not verified by the FDA and can vary; only products dispensed through the licensed pharmacy system with a prescription are subject to standard oversight.
Semaglutide questions
How much does Semaglutide cost?
Across the licensed providers tracked here, a full 3-month protocol of Semaglutide totals $114 to $114, depending on the provider, dose, and what is included. We average every cost to a standard 3-month protocol, which our medical advisors consider the best basis for comparing cost and value, and the total folds in any one-time consult or provider-review fee and three months of membership. The providers listing Semaglutide sell it by the vial, so the 3-month figure is an estimate of about one vial per month; the exact vial count depends on your dose and protocol. Each price shows the date the provider's sticker price was verified.
Is semaglutide FDA-approved?
Yes. It is approved as branded prescription products: Ozempic and Rybelsus for type 2 diabetes, and Wegovy for chronic weight management. Compounded semaglutide is a separate, non-FDA-approved category that some licensed pharmacies have dispensed during recognized shortages.
What is the difference between the branded and compounded versions?
Branded products are FDA-approved and manufactured under regulated conditions. Compounded semaglutide is prepared by compounding pharmacies and is not FDA-approved. Its availability depends on shortage status and applicable law, and its quality is not verified by the FDA.
How do cost and access typically work?
Access generally requires a prescription and a clinical evaluation. Costs vary widely depending on the specific product, formulation, insurance coverage, and pharmacy. Coverage for weight-management indications differs from coverage for diabetes and varies by plan.
Related reading
- What a GLP-1 subscription actually includesA breakdown of the parts that make up a telehealth GLP-1 subscription, from the consult and membership to labs and shipping, and why the advertised monthly number rarely matches what you pay.
- How to check that a peptide pharmacy is actually licensedA practical walkthrough of state board lookups, the difference between 503A and 503B pharmacies, and the warning signs that separate a real licensed pharmacy from a research-chemical seller.
- How to Get Peptides Safely and LegallyHow to get peptides through the legal, licensed pathway: prescriptions, 503A/503B pharmacies, honest evidence, and how to avoid the research-use-only gray market.
- Is Peptide Therapy Right for You?An independent guide to weighing peptide therapy: legality, what the research actually shows, who should avoid it, and how to find safe, licensed care.
- Peptides and GLP-1s for Weight ManagementAn independent look at GLP-1s and peptides for weight management: what the research shows, honest limits, safety, legality, and finding licensed care.
- The Compounded Semaglutide Crackdown, ExplainedWhat the FDA's move to end compounded semaglutide means, what the research actually shows, and how to find GLP-1 care inside the licensed pharmacy system.
- Peptide Access in 2026: What's Legal, What's RestrictedAn independent look at peptide access in 2026: which compounds are legal, which are restricted, what the evidence shows, and how to find licensed treatment.
- Peptide Therapy Side Effects: An Evidence-Based GuideAn independent, evidence-based look at peptide therapy side effects by compound class, gray-market supply risk, and how to find safe, legal treatment.
- Why Isn't My GLP-1 Working?Why your GLP-1 may not seem to be working: what research shows about varied response, differences between agents, and how to find safe, legal care.